Market Cap (In TWD)
749.55 Million
Revenue (In TWD)
231.83 Million
Net Income (In TWD)
-47.35 Million
Avg. Volume
18.75 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 22.5-37.35
- PE
- -17.55
- EPS
- -1.02
- Beta Value
- 0.096
- ISIN
- TW0006814007
- CUSIP
- -
- CIK
- -
- Shares
- 41874400.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chaoan Liu
- Employee Count
- -
- Website
- https://lukas-bio.com.tw
- Ipo Date
- 2020-12-31
- Details
- Lukas Biomedical Inc. engages in the development of immune cell medical technology for regenerative medicine and auxiliary treatment of cancer in Taiwan. It operates through four divisions: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. The company also wholesales and retails cosmetics; and rents housing equipment. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei, Taiwan.
More Stocks
-
VOW3Volkswagen AG
VOW3
-
MEGA
-
ENJPYen-japan inc.
ENJPY
-
000812
-
MAN
-
BOF
-
5523
-
EFE